The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 31, 2012
Filed:
Feb. 10, 2004
Anthony Storey, Amersham, GB;
Julie Davis, Amersham, GB;
Sally-ann Ricketts, Amersham, GB;
Marivi Mendizabal, Amersham, GB;
Alan Cuthbertson, Oslo, NO;
Joseph Arukwe, Oslo, NO;
Kirsty Heywood, Amersham, GB;
Ian Wilson, Amersham, GB;
Duncan Wynn, Amersham, GB;
Michael Schafers, Munster, DE;
Bodo Levkau, Munster, DE;
Stefan Wagner, Munster, DE;
Hans-jörg Breyholz, Munster, DE;
Klaus Kopka, Munster, DE;
Anthony Storey, Amersham, GB;
Julie Davis, Amersham, GB;
Sally-Ann Ricketts, Amersham, GB;
Marivi Mendizabal, Amersham, GB;
Alan Cuthbertson, Oslo, NO;
Joseph Arukwe, Oslo, NO;
Kirsty Heywood, Amersham, GB;
Ian Wilson, Amersham, GB;
Duncan Wynn, Amersham, GB;
Michael Schafers, Munster, DE;
Bodo Levkau, Munster, DE;
Stefan Wagner, Munster, DE;
Hans-Jörg Breyholz, Munster, DE;
Klaus Kopka, Munster, DE;
GE Healthcare Limited, Little Chalfont, GB;
Abstract
The present invention relates to the field of diagnostic imaging. Specifically, the invention relates to the diagnostic imaging of diseases where specific matrix metalloproteinases are known to be involved. One embodiment of the invention is a compound having matrix metalloproteinase inhibitory activity suitable for diagnostic imaging. Also disclosed in the present invention is a pharmaceutical composition comprising the diagnostic imaging agent of the invention in a form suitable for mammalian administration. The invention furthermore discloses intermediates in the synthesis of the diagnostic imaging agents of the invention and kits for the preparation of the pharmaceutical composition of the invention. The pharmaceutical composition of the invention may be used in the diagnosis of diseases where specific matrix metalloproteinases are known to be involved.